Alexis Balvair

Alexis Balvair

Healthcare Technology Expert
Alexis Balvair is a top voice in healthcare technology, exploring both core and emerging technologies in medicine. Alexis’ content helps healthcare professionals evaluate the available technology for procedures, medical interventions, and patient management, empowering healthcare professionals to stay ahead of the curve with emerging technologies. Alexis provides use cases to highlight the potential impact of these technologies in the industry.
Why Is Tolerability the New Standard for Digital Health?
Technology Why Is Tolerability the New Standard for Digital Health?

The modern medical landscape has reached a critical juncture where the sheer availability of digital health tools no longer serves as a reliable barometer for patient success or improved clinical outcomes. For several years, developers and healthcare providers prioritized engagement metrics,

How Can Governance Bridge the Healthcare AI Trust Gap?
Data and Information How Can Governance Bridge the Healthcare AI Trust Gap?

The seamless integration of predictive analytics into the modern clinical workflow has highlighted a profound tension between rapid technological acceleration and the essential requirement for medical safety. While the promise of artificial intelligence is vast, its successful implementation

How Is Commure Scaling AI to Modernize Healthcare Systems?
Business How Is Commure Scaling AI to Modernize Healthcare Systems?

The contemporary healthcare landscape is currently undergoing a radical transformation as the industry moves away from fragmented software toward unified AI-native operating systems. Commure has recently solidified its position at the forefront of this movement by securing a seventy million dollar

FDA Approves Datroway for Triple-Negative Breast Cancer
Public Policy FDA Approves Datroway for Triple-Negative Breast Cancer

The landscape of oncological treatment has reached a historic juncture with the FDA’s decision to integrate targeted antibody-drug conjugates into the frontline management of the most aggressive malignancies. Triple-negative breast cancer has long presented a formidable biological challenge because

How Can Healthcare Payers Close the Personalization Gap?
Data and Information How Can Healthcare Payers Close the Personalization Gap?

In this insightful discussion, Faisal Zain, a veteran in the field of medical technology and member engagement strategy, breaks down the critical challenges facing modern health plans. With margins tightening and member expectations rising, the conversation centers on the shift from fragmented

Can a Flexible AI Skin Patch Save Lives in Real Time?
Data and Information Can a Flexible AI Skin Patch Save Lives in Real Time?

The critical gap between monitoring a medical emergency and delivering life-saving intervention often comes down to the milliseconds wasted while data travels between a wearable device and a distant server. While modern smartwatches and fitness trackers offer impressive heart rate tracking and

Can Fountain Health Partners Close the Healthcare Scaling Gap?
Organizational Governance Can Fountain Health Partners Close the Healthcare Scaling Gap?

The transition from a successful pilot program to a broad, commercially viable healthcare enterprise often represents an insurmountable barrier for many promising startups in the current economic landscape. While venture capital frequently flows toward the early stages of discovery or the

Can Tennessee’s SB 2040 Restore Pharmacy Competition?
Care Can Tennessee’s SB 2040 Restore Pharmacy Competition?

The landscape of the American pharmaceutical supply chain has reached a critical inflection point where the sheer density of corporate consolidation now threatens the very existence of local healthcare providers. Tennessee’s Senate Bill 2040 (SB 2040) represents a pivotal legislative effort to r

Can Non-Viral Delivery Solve Gene Therapy’s Biggest Flaw?
Care Can Non-Viral Delivery Solve Gene Therapy’s Biggest Flaw?

Faisal Zain is a seasoned figure in the medical technology sector, known for bridging the gap between complex engineering and patient-centered diagnostics. As the landscape of genetic medicine shifts away from traditional viral vectors, Zain provides essential context on the rise of non-viral

Can Cagent Vascular’s New Tech Disrupt the IVL Market?
Technology Can Cagent Vascular’s New Tech Disrupt the IVL Market?

Vascular surgeons have long struggled with the "rock-hard" challenge of heavily calcified arterial walls that resist traditional balloon angioplasty and stenting procedures. This persistent clinical hurdle has driven a massive surge in investment within the medical technology sector, most

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later